Eli Lilly antibody drug fails in a COVID-19 study; others go on

Independent monitors had paused enrolment in the study two weeks ago because of a possible safety issue.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.